Allergy Therapeutics plc (AGYTF)

USD 0.05

(0.0%)

Annual Balance Sheets

(In GBP)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 68.4 Million 73.58 Million 88.08 Million 86.22 Million 68.49 Million 51.01 Million
Total Current Assets 34.21 Million 42.39 Million 57.85 Million 55.17 Million 46.62 Million 30.92 Million
Cash And Short Term Investments 14.84 Million 20.51 Million 40.27 Million 36.96 Million 27.44 Million 15.53 Million
Cash and Cash Equivalents 14.84 Million 20.51 Million 40.27 Million 36.96 Million 27.44 Million 15.53 Million
Short Term Investments - - - - - -
Net Receivables 7.77 Million 10.46 Million 6.22 Million 8.07 Million 9.77 Million 6.58 Million
Inventory 11.59 Million 11.41 Million 10.83 Million 10.13 Million 9.4 Million 8.8 Million
Other Current Assets 4.72 Million 7.77 Million 525 Thousand 4.58 Million 5.28 Million 2.76 Million
Total Non-Current Assets 34.19 Million 31.18 Million 30.23 Million 31.05 Million 21.87 Million 20.08 Million
Net PPE 23.97 Million 20.19 Million 19.71 Million 20.41 Million 11.48 Million 10.09 Million
Good Will And Intangible Assets 4.4 Million 5.03 Million 4.75 Million 4.73 Million 4.84 Million 4.94 Million
Good Will 3.34 Million 3.34 Million 3.34 Million 3.46 Million 3.43 Million 3.4 Million
Intangible Assets 1.05 Million 1.68 Million 1.41 Million 1.26 Million 1.4 Million 1.54 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 5.81 Million 5.96 Million 5.76 Million 5.9 Million 5.55 Million 5.04 Million
Other Assets - - - - - -
Total Liabilities 73.18 Million 35.18 Million 39.55 Million 42.44 Million 30.93 Million 27.98 Million
Total Current Liabilities 19.05 Million 17.8 Million 18.23 Million 18.22 Million 16.85 Million 14.63 Million
Account Payables 17.17 Million 15.66 Million 16.47 Million 15.14 Million 15.73 Million 13.89 Million
Tax Payables 4.44 Million 4.26 Million 3.75 Million 4.44 Million 1.87 Million 2.21 Million
Short Term Debt 1.8 Million 2.01 Million 1.75 Million 2.26 Million 694 Thousand 644 Thousand
Deferred Revenue - - -13.57 Million - - -
Other Current Liabilities 79 Thousand 116 Thousand 13.57 Million 815 Thousand 429 Thousand 97 Thousand
Total Non Current Liabilities 54.12 Million 17.38 Million 21.32 Million 24.21 Million 14.08 Million 13.35 Million
Long-Term Debt 34.59 Million 8.51 Million 9.41 Million 9.91 Million 1.74 Million 2.41 Million
Deferred Revenue Non Current 7.9 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 11.28 Million 8.46 Million 11.49 Million 13.83 Million 12.02 Million 10.62 Million
Other Liabilities - - - - - -
Total Equity -4.78 Million 38.39 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Stock Holders Equity -4.78 Million 38.39 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Common Stock 689 Thousand 644 Thousand 641 Thousand 637 Thousand 636 Thousand 606 Thousand
Retained Earnings -168.71 Million -117.91 Million -107.39 Million -112.96 Million -119.17 Million -121.75 Million
Accumulated other comprehensive income 2.58 Million 2.94 Million 2.57 Million 3.39 Million 3.38 Million 1.63 Million
Common Stock Equity -4.78 Million 38.39 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Capital Lease Obligation 8.9 Million 8.08 Million 7.75 Million 8.42 Million - -
Total Investments - - - - - 5.04 Million
Total Debt 36.39 Million 10.52 Million 11.17 Million 12.17 Million 2.43 Million 3.05 Million
Net Debt 21.55 Million -9.98 Million -29.1 Million -24.78 Million -25 Million -12.47 Million

Balance Sheet Charts